← Evidence map

TrialPharmacoEconomics1994

Economic evaluation of lenograstim (glycosylated rHuG-CSF) in the treatment of inflammatory breast cancer for Germany and Italy.

V Mapelli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

1994

1995

1996

1997

1998

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

this paperpooled ittrialcites it

Economic evaluation of lenograstim (glycosylated rHuG-CSF) in the treatment of inflammatory breast cancer for Germany and Italy. | OpenQuestion